N/A N=63 Randomized Single-blind Treatment

Idiopathic Hypertensive Anal Canal: a Place of Internal Sphincterotomy

Hypertensive Anal Canal

Bottom Line

View on ClinicalTrials.gov: NCT00927849 ↗

Enrolled (actual)

Serious AEs

—

Results posted

Jun 2009

Primary outcome: Primary: Effect of Closed Lateral Sphincterotomy and Chemical Sphincterotomy on Hypertensive Anal Canal

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: lateral internal sphincterotomy (LIS) (Procedure); Glycerin trinitrate (GTN) (Drug); botulinum toxin injection (BTX A) (Drug)
Age: Adult · 18+ yrs
Sex: All
Sponsor: Mansoura University
Primary completion: Apr 2008

Outcome Measures

Outcome	Result	p-value
PRIMARY Effect of Closed Lateral Sphincterotomy and Chemical Sphincterotomy on Hypertensive Anal Canal	—	—
PRIMARY Relieve of Anal Pain	4.16; 4.18; 4.2	—

Summary

Idiopathic hypertensive anal canal is a fact and already exists presented by anal pain aggravated by defecation. It can be managed safely by closed lateral sphincterotomy but chemical sphincterotomy had a minor role in its management.

Eligibility Criteria

Inclusion Criteria

all patients with hypertensive anal canal

Exclusion Criteria

patients who had any pathological anorectal lesions such as anal fissure, piles, rectal prolapse, intussusception, anismus, cancer, patients with normal anal pressure
patients who previously had anorectal surgery, chemical or surgical sphincterotomy, anal dilatation, IBD, venereal disease, neurological disorder or systemic gastrointestinal disease

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00927849). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.